AP-1 and colorectal cancer
- 1 August 2005
- journal article
- review article
- Published by Springer Nature in Inflammopharmacology
- Vol. 13 (1-3) , 113-125
- https://doi.org/10.1163/156856005774423935
Abstract
Activator protein-1 (AP-1) is a transcription factor that consists of either a Jun-Jun homodimer or a Jun-Fos heterodimer. AP-1 regulates the expression of multiple genes essential for cell proliferation, differentiation and apoptosis. Numerous reports suggest that AP-1 plays an important role in various human diseases. Among them, the roles relating to human cancers have been strongly suggested for a long time. In human cancers, colorectal cancer is still a leading cause of morbidity and mortality in the world. Since there are some reports about the role of AP-1 in colorectal cancer response to a number of stimuli, such as cytokines and growth factors, and oncogenic transformation, therapeutic inhibition of AP-1 activity has attracted considerable interest. Here, we demonstrate the biological properties of AP-1 and its role in colorectal cancer, and discuss a possibility of an AP-1 inhibitor, an adenovirus dominant-negative mutant of c-Jun, as a therapeutic a gent for gene therapy.Keywords
This publication has 69 references indexed in Scilit:
- Inhibition of Activator Protein 1 Activation, Vascular Endothelial Growth Factor, and Cyclooxygenase-2 Expression by 15-Deoxy-Δ12,14-Prostaglandin J2 in Colon Carcinoma Cells: Evidence for a Redox-Sensitive Peroxisome Proliferator-Activated Receptor-γ-Independent MechanismCancer Research, 2004
- Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancerGene Therapy, 2004
- Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4Trends in Molecular Medicine, 2003
- AP-1 as a regulator of cell life and deathNature Cell Biology, 2002
- AP-1 blockade inhibits the growth of normal and malignant breast cellsOncogene, 2001
- AP-1 in mouse development and tumorigenesisOncogene, 2001
- AP-1 in cell proliferation and survivalOncogene, 2001
- Induced expression of dominant-negative c-jun downregulates NF?B and AP-1 target genes and suppresses tumor phenotype in human keratinocytesMolecular Carcinogenesis, 2000
- Transcriptional regulation of cell invasionEuropean Journal Of Cancer, 2000
- Transcriptional Repression of p21(Waf1/Cip1/Sdi1) Gene by c-jun through Sp1 SiteBiochemical and Biophysical Research Communications, 2000